Cannabis is the most widely used recreational drug worldwide. The Substance Abuse and Mental Health Services Administration (SAMHSA), a branch of the U.S. Department of Health, estimated that 19 million people in the US had cannabis use disorder (CUD) in 2022.

​

The main reasons for the increase in CUD/CWS are the dramatic increase in THC potency (this is not your parents' cannabis) and the increasing numbers of people who use cannabis on a daily basis, along with growing public acceptance, increased legalization, ease of accessibility, and the perception that cannabis can be used to treat a variety of conditions.
 
Cannabis withdrawal can, in some people, develop within hours of last cannabis use driving them to use multiple times a day. These symptoms may be severe for many and typically include anxiety, irritability, cravings, sleep problems, abdominal pain, loss of appetite, restlessness, and depression as well as other physical symptoms. Importantly, these are often not recognized as withdrawal symptoms by patients or their healthcare providers.
 

PleoPharma believes that people should not have to suffer needlessly if for whatever reason they choose to reduce or stop using cannabis. It is our mission to provide a safe and effective treatment option to mitigate cannabis withdrawal syndrome and help patients open the door to a healthier life.

​

Our mission is to help, without judging, those who seek help and who have no tools or options to avoid CWS.
 

Thank you for taking the time to read our story and our mission.

The PleoPharma Team